Calumet Statistics
Total Valuation
Calumet has a market cap or net worth of $1.72 billion. The enterprise value is $3.93 billion.
Important Dates
The next estimated earnings date is Friday, February 27, 2026, before market open.
| Earnings Date | Feb 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Calumet has 86.75 million shares outstanding. The number of shares has increased by 6.00% in one year.
| Current Share Class | 86.75M |
| Shares Outstanding | 86.75M |
| Shares Change (YoY) | +6.00% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 4.08% |
| Owned by Institutions (%) | 39.21% |
| Float | 56.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.42 |
| Forward PS | 0.41 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.97 |
| EV / EBITDA | 11.25 |
| EV / EBIT | 20.09 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.13
| Current Ratio | 1.13 |
| Quick Ratio | 0.48 |
| Debt / Equity | n/a |
| Debt / EBITDA | 6.59 |
| Debt / FCF | n/a |
| Interest Coverage | 0.86 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 4.55% |
| Return on Invested Capital (ROIC) | 6.78% |
| Return on Capital Employed (ROCE) | 10.00% |
| Revenue Per Employee | $2.50M |
| Profits Per Employee | -$22,963 |
| Employee Count | 1,620 |
| Asset Turnover | 1.51 |
| Inventory Turnover | 9.04 |
Taxes
| Income Tax | -41.40M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.02% in the last 52 weeks. The beta is 1.23, so Calumet's price volatility has been higher than the market average.
| Beta (5Y) | 1.23 |
| 52-Week Price Change | -7.02% |
| 50-Day Moving Average | 19.47 |
| 200-Day Moving Average | 16.21 |
| Relative Strength Index (RSI) | 53.34 |
| Average Volume (20 Days) | 783,713 |
Short Selling Information
The latest short interest is 7.87 million, so 9.07% of the outstanding shares have been sold short.
| Short Interest | 7.87M |
| Short Previous Month | 7.91M |
| Short % of Shares Out | 9.07% |
| Short % of Float | 13.81% |
| Short Ratio (days to cover) | 13.81 |
Income Statement
In the last 12 months, Calumet had revenue of $4.05 billion and -$37.20 million in losses. Loss per share was -$0.43.
| Revenue | 4.05B |
| Gross Profit | 390.60M |
| Operating Income | 195.70M |
| Pretax Income | -78.60M |
| Net Income | -37.20M |
| EBITDA | 349.40M |
| EBIT | 195.70M |
| Loss Per Share | -$0.43 |
Full Income StatementBalance Sheet
The company has $94.60 million in cash and $2.30 billion in debt, with a net cash position of -$2.21 billion or -$25.45 per share.
| Cash & Cash Equivalents | 94.60M |
| Total Debt | 2.30B |
| Net Cash | -2.21B |
| Net Cash Per Share | -$25.45 |
| Equity (Book Value) | -449.70M |
| Book Value Per Share | -8.01 |
| Working Capital | 103.80M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$11.00 million and capital expenditures -$64.60 million, giving a free cash flow of -$75.60 million.
| Operating Cash Flow | -11.00M |
| Capital Expenditures | -64.60M |
| Free Cash Flow | -75.60M |
| FCF Per Share | -$0.87 |
Full Cash Flow StatementMargins
Gross margin is 9.65%, with operating and profit margins of 4.83% and -0.92%.
| Gross Margin | 9.65% |
| Operating Margin | 4.83% |
| Pretax Margin | -1.94% |
| Profit Margin | -0.92% |
| EBITDA Margin | 8.63% |
| EBIT Margin | 4.83% |
| FCF Margin | n/a |
Dividends & Yields
Calumet does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.00% |
| Shareholder Yield | -6.00% |
| Earnings Yield | -2.16% |
| FCF Yield | -4.39% |
Dividend DetailsAnalyst Forecast
The average price target for Calumet is $20.45, which is 2.87% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $20.45 |
| Price Target Difference | 2.87% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 5.70% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Calumet has an Altman Z-Score of 1.24 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.24 |
| Piotroski F-Score | 4 |
